{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-060286","form_type":"8-K/A","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2022-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.015377+00:00","generated_at":"2026-06-25T16:24:50.902115+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Collegium files BDSI acquisition pro forma; $669M total consideration, $75M annual synergy target","bullets":["Total consideration for BDSI acquisition: $669.4M ($606.4M cash to stockholders at $5.60/share + $63.0M to retire BDSI debt).","Pro forma combined 2021 revenue $443.6M, net income $23.5M after $132.9M in transaction-related adjustments.","Company expects at least $75M in annual run-rate cost synergies within 12 months of closing (headcount reductions and consolidation).","Acquisition financed via a new $650.0M term loan (modification of existing Collegium term loan); BDSI term loan paid at close.","Preliminary purchase price allocation includes $445M in identifiable intangible assets (Belbuca, Symproic, Elyxyb) and $134M in goodwill."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-060286","json":"https://secwatch.observer/filing/0001104659-22-060286.json","markdown":"https://secwatch.observer/filing/0001104659-22-060286.md","text":"https://secwatch.observer/filing/0001104659-22-060286.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465922060286/0001104659-22-060286-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465922060286/tm2215301d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T16:24:50.902115+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}